Dr. Kanwaljeet Sunny Anand is a translational clinical researcher who pioneered research on the endocrine-metabolic stress responses of infants undergoing surgery and developed the first-ever scientific rationale for pain perception in early life. This provided a framework for newer methods of pain assessment, numerous clinical trials of analgesia/anesthesia in newborns, infants and older children.

Inadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But researchers know remarkably little about these solutes. Dr. Timothy Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. Dr. Meyer's group hopes to improve treatment by finding out more about what we are trying to remove.

Dr. Wendy Gu's group studies the mechanical behavior of nanomaterials. They work at the intersection of solid mechanics, materials science and nano-chemistry. They research the unique properties of nanoscale metals, ceramics and nano-architected composites in order to design strong, tough and lightweight structural materials, materials for extreme environments, and mechanically-actuated sensors. The Gu group's experimental tools include nanoindentation, electron microscopy, and colloidal synthesis.

Dr. Marshall Burke is an assistant professor in the Department of Earth System Science, deputy director at the Center on Food Security and the Environment, and center fellow at the Freeman Spogli Institute for International Studies (FSI) at Stanford University. He is also a faculty research fellow at the National Bureau of Economic Research, and a co-founder of AtlasAI, a remote sensing start-up.

The focus of Dr. Silvana Konermann's lab is to develop and apply technologies for high-throughput transcriptional perturbations to understand the cellular and molecular pathways driving human genetic risk in neurodegenerative disease

Dr. Scott Linderman works in the fields of machine learning and computational neuroscience. Dr. Linderman's lab focuses on developing probabilistic models and inference algorithms to better understand complex biological datasets.

Dr. Benjamin Lev's research focuses on exploring the organizing principles of quantum matter through the development of techniques at the interface of ultracold atomic physics, quantum optics, and condensed matter physics.  Dr. Lev's major achievements and current projects include:

Dr. Bali Pulendran’s work focuses on understanding the mechanisms by which the innate immune system regulates adaptive immunity and harnessing such mechanisms in the design of novel vaccines against global pandemics. More recently, he has begun to apply systems biological approaches to predicting the efficacy of vaccines, and deciphering new correlates of protection against infectious diseases.

Dr. Jonathan Lin's group investigates mechanisms of human eye and brain diseases, and they test new therapies to diagnose and treat these diseases.

Dr. Hannes Vogel's chief research interests are in mitochondrial diseases, muscle and nerve diseases, brain tumors, and animal models of human disease. Dr. Vogel is also the Director of the Stanford Research Core Histology Laboratory, which is of central importance to many Stanford research endeavors and to medical scientist development.